| Inventor | Institute |
|---|---|
| Anne Savitt | Stony Brook University |
| SKU: | 154041 |
|---|---|
| Product description: | This mouse IgG2a monoclonal is reactive against both F. tularensis LVS and F. tularensis SchuS4 protein sucB. Francisella tularensis is a small pathogenic gram-negative bacterium that causes tularemia. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | 64 kDa |
| Immunogen: | Sublethal infection with F. tularensis LVS |
| Cat. #: | 154041 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Microbiology |
| Application: | ELISA ; IF ; IP ; WB |
| Target: | sucB |
| Reactivity: | Francisella tularensis |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | This mouse IgG2a monoclonal is reactive against both F. tularensis LVS and F. tularensis SchuS4 protein sucB. Francisella tularensis is a small pathogenic gram-negative bacterium that causes tularemia. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Savitt et al. 2009. Clin Vaccine Immunol. 16(3):414-22. PMID: 19176692. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. |
|---|
| Cat. # | Tool Name | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.